David Hui, PhD, Named Director of Metabolic Diseases Research Center
In an effort to expand multidisciplinary research at the University of Cincinnati (UC) College of Medicine, David Hui, PhD, a professor in the department of pathology and laboratory medicine, has been named director of the Metabolic Diseases Research Center.
Hui, a leading researcher in lipid disorders as they relate to diabetes, obesity and coronary heart disease (atherosclerosis), has been at the medical college for 28 years and was formerly the departments vice chair of research.
Hui will lead the center from UCs Reading Campus, located 2180 E. Galbraith Road in Reading, Ohio, which is a hub for UC scientists involved in high-profile research initiatives such as diabetes and obesity, lipid and arteriosclerosis, fatty liver disease and cirrhosis, and cancer metabolism. The campus is also home to neuroscience, cardiovascular and cancer researchers whose work fits under the "metabolism umbrella.
Hui, however, says he also wants to reach across to UC Health and Cincinnati Childrens Hospital Medical Center campuses to create an all-inclusive environment that supports collaborative and translational research: "We have pockets of strengths in different departments, so what I would like to do is bring them together so that they can collaborate, and I want to talk to clinicians about how we can help humans.
Hui was named director by Thomas Boat, MD, dean of the College of Medicine, who says: "The center concept is where we need to be in terms of organizing research efforts for the future.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.